Attana will participate at the Drug Discovery Innovation Programme in Munich on October 5-6, 2022

On October 5-6, Attana will participate at the Drug Discovery Innovation Programme in Munich, Germany. The conference includes meetings with C-level Drug Discovery & Development executives mainly from small and mid-size pharma and biotech companies.

As a starter to the event, Attana together with BiotechBikers hosts a cycling tour on Tuesday October 4 at 14.00.

When: October 4, 14.00

How far: Around 50 km

Can I rent a bike: Yes - information on request

More details and sign-up to the cycling event can be found by following this link: https://biotechbikers.com/upcoming-events

For more information, please contact:

Teodor Aastrup, CEO
teodor.aastrup@attana.com
+46 (0)8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.

About Attana

Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com